Abiopharma

🔍 Castillo Daniel J (Executive)

Company: WESCO INTERNATIONAL INC (WCC)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 1,400 shares of Common Stock at $266.06 per share (Direct)
  Date: 2026-03-31 | Code: P | equity_swap_involved: false | shares_owned_after: 15,300.03 | transaction_form_type: 4
• Acquired 25 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: false | shares_owned_after: 15,325.16 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,400 shares of Stock Options (Right to Buy) at $273.62 per share (Derivative)
  Date: 2026-03-31 | Code: A | Expires: 2036-03-31 | equity_swap_involved: false | shares_owned_after: 1,400.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents dividend equivalent rights ("DERs") in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on restricted stock units ("RSUs") held by the Reporting Person. Each DER is the economic equivalent of one share of Issuer's common stock and vests on the same schedule as the underlying award.
• F2: The stock options become exercisable in three equal annual installments beginning on the first anniversary of the date of grant.